TABLE 1.
Subject no. | Value for tigecycline in:
|
|||||||
---|---|---|---|---|---|---|---|---|
Serum
|
Blister fluid
|
|||||||
Tmax (h) | Cmax (ng/ml) | AUC0-12 (ng · h/ml) | t1/2 (h)a | Tmax (h) | Cmax (ng/ml) | AUC0-12 (ng · h/ml) | t1/2 (h) | |
1 | 0.5 | 804 | 2,408 | ND | 6.0 | 1,157 | 1,649 | 9.5 |
2 | 0.5 | 853 | 2,552 | 47.3 | 3.0 | 194 | 1,932 | 12.6 |
3 | 0.5 | 864 | 2,356 | 60.5 | 6.0 | 183 | 1,766 | 13.6 |
4 | 0.5 | 928 | 2,243 | 45.4 | 1.0 | 223 | 1,731 | 9.7 |
5 | 0.5 | 967 | 2,073 | 56.6 | 4.0 | 146 | 1,396 | 9.9 |
6 | 0.5 | 771 | 2,617 | ND | 3.0 | 201 | 1,823 | 11.7 |
7 | 0.5 | 716 | 1,786 | 26.2 | 0.5 | 129 | 1,296 | 16.8 |
8 | 0.5 | 674 | 1,819 | 27.2 | 2.0 | 162 | 1,330 | 9.0 |
9 | 0.5 | 954 | 2,268 | ND | 1.0 | 177 | 1,583 | 14.2 |
10 | 0.5 | 662 | 1,730 | 51.0 | 1.0 | 160 | 1,584 | 10.7 |
Mean | 0.5 | 819 | 2,185 | 44.9 | 2.8 | 273 | 1,609 | 11.8 |
SD | 0.0 | 113 | 320 | 13.5 | 2.0 | 312 | 214 | 2.5 |
ND, not determined in individual subject because of insufficient data points.